Anakinra to prevent blood clots in kidney transplant patients
Treatments studied
Part of Blood & lymphatic, Heart & circulation clinical trials.
This trial tests whether a medicine called anakinra, which reduces inflammation, can prevent blood clots forming in the kidney after a transplant. It may help improve the chances of the new kidney working well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a kidney transplant (with or without another organ).
- You can give written consent to take part.
- Women must use effective birth control, be past menopause, or have had surgical sterilization.
- Men must agree to use condoms during the trial and for 3 months after the last dose.
- You must not have active tuberculosis, hepatitis B, or low white blood cell count.
- You must be able to understand French and not be in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving you back specially grown immune cells (called Tregs) made from your own blood can help your body accept a new kidney from a living donor with less rejection. It is for people who are ready for a first kidney transplant.
This trial tests a specific “induction” treatment to help people who have stronger immune reactions from past sensitizing events during a kidney transplant. It may help improve how well the transplant works and how safely the immune system is managed.
This trial tests whether giving albumin (a protein in your blood) after a liver transplant can help prevent or reduce kidney damage. It is for adults receiving their first liver-only transplant from a deceased donor.
This trial tests whether giving a drug that blocks a protein called IL-1 (which causes inflammation and fluid buildup) can reduce swelling in donor lungs before they are transplanted. If you are getting a lung transplant and your donated lung is treated with a special machine, this study may help improve the lung's condition.
This trial studies whether belatacept can be used after a heart transplant to help protect kidney function over time. It focuses on people who already have (or are at risk for) worsening kidney function after transplant, while avoiding those with certain infections or rejection concerns.
This trial tests a drug called anakinra to see if it can prevent severe drops in blood sugar after eating in people who have had their stomach removed. It is designed for one person, so results may not apply to everyone.
Hear when a new Pancreatic Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.